insights_auto
Why is ZTS down 5,63%?
Dive Deeperchevron_right
ZTS:NYSE
Zoetis Inc
80,79 USD
arrow_downward
-5,63%(-4,82) 1D
80,96 USD
arrow_upward
+0,21% (+0,17)bedtimeAfter hours
Closed: 19-ноя., 16:02:16 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZTS...
Open
84,84 USD
High
85,13 USD
Low
80,71 USD
Mkt. cap
32,83 млд
Avg. vol.
4,46 млн
Volume
4,71 млн
Dividend
2,62%
Quarterly dividend
0,53 USD
Ex-dividend date
2026-ж., 30-окт.
P/E ratio
13,72
52-wk high
132,49 USD
52-wk low
68,77 USD
EPS
5,89 USD
Beta
0,67
Shares outstanding
406,32 млн
No. of employees
14 миң
Open
84,84 USD
High
85,13 USD
Low
80,71 USD
Mkt. cap
32,83 млд
Avg. vol.
4,46 млн
Volume
4,71 млн
Dividend
2,62%
Quarterly dividend
0,53 USD
Ex-dividend date
2026-ж., 30-окт.
P/E ratio
13,72
52-wk high
132,49 USD
52-wk low
68,77 USD
EPS
5,89 USD
Beta
0,67
Shares outstanding
406,32 млн
No. of employees
14 миң
News stories
From web sources and news partners
GuruFocus
·
4 саат мурун
Zoetis Inc (ZTS) Stock Down 5.6% -- Now Undervalued? GF Score: 7
MarketWatch
·
5 саат мурун
Zoetis Inc. stock underperforms Thursday when compared to competitors
Yahoo Finance
·
10 саат мурун
Is New Poultry Vaccine Altering The Investment Case For Zoetis Stock?
Yahoo Finance
·
11 саат мурун
Zoetis (ZTS) Climbed, So What Is Behind The Latest Attention?
Profile
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
About Zoetis Inc
CEOKristin C. Peck
Employees14,5 миң
Founded1952
HeadquartersParsippany-Troy Hills, Нью Джерси, Америка Кошмо Штаттары
SectorHealth Care
IndustryPharmaceutical industry
Websitezoetis.com